Genomic variation of human papillomavirus type 16 and risk for high grade cervical intraepithelial neoplasia

Journal of the National Cancer Institute

Volumn 89, Issue 11, 1997, Pages 796-802

  Xi, Long Fu ^a   Koutsky, Laura A ^a   Galloway, Denise A ^b   Kuypers, Jane ^a   Hughes, James P ^a   Wheeler, Cosette M ^c   Holmes, King K ^a   Kiviat, Nancy B ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER RISK; FEMALE; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; UTERINE CERVIX CARCINOMA IN SITU; VIRUS CARCINOGENESIS; VIRUS GENOME; WART VIRUS;

EID: 1842417125     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/89.11.796     Document Type: Article

References (32)

1. VanRanst MA, Tachezy R, Delius H, Burk RD. Taxonomy of the human papillomaviruses. Papillomavirus Rep 1993;4:61-5.
2. De Villiers EM. Heterogeneity of the human papillomavirus group. J Virol 1989;63:4898-903.
3. Koutsky LA, Holmes KK, Critchlow CW, Stevens CE, Paavonen J, Beckmann AM, et al. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med 1992; 327:1272-8.
4. Schiffman MH, Bauer HM, Hoover RN, Glass AG, Cadell DM, Rush BB, et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 1993;85: 958-64.
5. Munoz N. HPV and cervical cancer: review of case control and cohort studies. In: Munoz N, Bosch FX, Shah KV, Meheus A, editors. Epidemiology of cervical cancer and human papillomavirus IARC Scientific Publ No. 119, Lyon: IARC 1992:251-62.
6. Ho GY, Burk RD, Klein S, Kadish AS, Chang CJ, Palan P, et al. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst 1995;87:1365-71.
7. Schiffman MH. Recent progress in defining the epidemiology of human papillomavirus infection and cervical neoplasia. J Natl Cancer Inst 1992;84:394-8.
8. Lacey CJ. Assessment of exposure to sexually transmitted agents other than human papillomavirus. In: Munoz N, Bosch FX, Shah KV, Meheus A, editors. Epidemiology of cervical cancer and human papillomavirus. IARC Scientific Publ No. 119, Lyon: IARC 1992:93-105.
9. Mittal R, Pater A, Pater MM. Multiple human papillomavirus type 16 glucocorticoid response elements functional for transformation, transient expression, and DNA protein interactions. J Virol 1993;67:5656-9.
10. May M, Dong XP, Beyer-Finkler E, Stubenrauch F, Fuchs PG, Pfister H. The E6/E7 promoter of extrachromosomal HPV16 DNA in cervical cancers escapes from cellular repression by mutation of target sequences for YY1. EMBO J 1994;13:1460-6.
11. Ho L, Chan SY, Burk RD, Das BC, Fujinaga K, Icenogle JP, et al. The genetic drift of human papillomavirus type 16 is a means of reconstructing prehistoric viral spread and the movement of ancient human populations. J Virol 1993;67:6413-23.
12. Chan SY, Ho L, Ong CK, Chow V, Drescher B, Duerst M, et al. Molecular variants of human papillomavirus type 16 from four continents suggest ancient pandemic spread of the virus and its coevolution with humankind. J Virol 1992;66:2057-66.
13. Yamada T, Wheeler CM, Halpern AL, Stewart AC, Hildesheim A, Jenison SA. Human papillomavirus type 16 variant lineages in United States populations characterized by nucleotide sequence analysis of the E6, L2, and L1 coding segments. J Virol 1995;69:7743-53.
14. Xi LF, Demers GW, Koutsky LA, Kiviat NB, Kuypers J, Watts DH, et al. Analysis of human papillomavirus type 16 variants indicates establishment of persistent infection. J Infect Dis 1995;172:747-55.
15. Schneider A, Koutsky LA. Natural history and epidemiological features of genital HPV infection. In: Munoz N, Bosch FX, Shah KV, et al., editors. Epidemiology of cervical cancer and human papillomavirus. IARC Scientific Publ No. 119, Lyon: IARC 1992:25-52.
16. Koutsky LA, Galloway DA, Holmes KK. Epidemiology of genital human papillomavirus infection. Epidemiol Rev 1988;10:122-63.
17. Kiviat NB, Koutsky LA, Paavonen J, Galloway DA, Critchlow CW, Beckmann A, et al. Prevalence of genital papillomavirus infection among women attending a college student health clinic or a sexually transmitted disease clinic. J Infect Dis 1989;159:293-302.
18. Kuypers JM, Critchlow CW, Gravitt PE, Vernon DA, Sayer JB, Manos MM, et al. Comparison of dot filter hybridization, Southern transfer hybridization, and polymerase chain reaction amplification for diagnosis of anal human papillomavirus infection. J Clin Microbiol 1993;31:1003-6.
19. Koss LG. Diagnostic cytology and its histopathologic bases. 3rd ed. Philadelphia: Lippincott, 1979.
20. Kiviat NB, Paavonen JA, Wolner-Hanssen P, Critchlow CW, Stamm WE, Douglas J, et al. Histopathology of endocervical infection caused by Chlamydia trachomatis, herpes simplex virus, Trichomonas vaginalis, and Neisseria gonorrhoeae. Hum Pathol 1990;21: 831-7.
21. Xi LF, Demers GW, Kiviat NB, Kuypers J, Beckmann AM, Galloway DA. Sequence variation in the noncoding region of human papillomavirus type 16 detected by single-strand conformation polymorphism analysis. J Infect Dis 1993;168:610-7.
22. Seedorf K, Krammer G, Durst M, Suhai S, Rowekamp WG. Human papillomavirus type 16 DNA sequence. Virology 1985;145:181-5.
23. Baker CC, Phelps WC, Lindgren V, Braun MJ, Gonda MA, Howley PM. Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines. J Virol 1987;61:962-71.
24. Wheeler CM, Yamada T, Hildesheim A, Jenison SA. Human papillomavirus type 16 sequence variants: identification by E6 and L1 lineage-specific hybridization. J Clin Microbiol 1997;35:11-9.
25. Cox DR. Regression models and life tables. J R Stat Soc (Series B) 1972;34:187-220.
26. Myers G, Bernard HU, Delius H, Baker C, Icenogel J, Halpern A, et al., editors. Human papillomaviruses 1995. A compilation and analysis of nucleic acid and amino acid sequences. Los Alamos (NM): Los Alamos National Laboratory, 1995.
27. Morrison EA, Ho GY, Vermund SH, Goldberg GL, Kadish AS, Kelley KF, et al. Human papillomavirus infection and other risk factors for cervical neoplasia: a case-control study. Int J Cancer 1991;49:6-13.
28. Villa LL, Franco EL. Epidemiologic correlates of cervical neoplasia and risk of human papillomavirus infection in asymptomatic women in Brazil. J Natl Cancer Inst 1989;81: 332-40.
29. Parazzini F, La Vecchia C, Negri E, Fedele L, Franceschi S, Gallotta L. Risk factors for cervical intraepithelial neoplasia. Cancer 1992;69: 2276-82.
30. Gould PR, Barter RA, Papadimitriou JM. An ultrastructural, cytochemical, and autoradiographic study of the mucous membrane of the human cervical canal with reference to subcolumnar basal cells. Am J Pathol 1979;95:1-16.
31. Ellis JR, Keating PJ, Baird J, Hounsell EF, Renouf DV, Rowe M, et al. The association of an HPV16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancer. Nat Med 1995;1:464-70.
32. Gloss B, Chong T, Bernard HU. Numerous nuclear proteins bind the long control region of human papillomavirus type 16: a subset of 6 of 23 DNase I-protected segments coincides with the location of the cell-type specific enhancer. J Virol 1989;63:1142-52.